Exploring the Pharmacological Mechanisms of P-hydroxylcinnamaldehyde for Treating Gastric Cancer: A Pharmacological Perspective with Experimental Confirmation
Our study presents novel evidence regarding pertinent potential target genes and signaling pathways through which CMSP mediates its anti-GC effects, with a particular emphasis on its role in modulating apoptotic signaling pathways. Collectively, these findings underscore the promising candidacy of CMSP as a therapeutic agent for GC that merits further investigation in clinical contexts.
Authors
- Lianmei Zhao (ORCID: https://orcid.org/0000-0002-5854-9827)
- Sumaya Fatima
- Kausar Malik (ORCID: https://orcid.org/0000-0001-6599-7719)
- Ruinian Zhao
- Yuhui Fu (ORCID: https://orcid.org/0000-0002-7487-4857)
- Yanru Song (ORCID: https://orcid.org/0000-0001-8802-0150)
- Zhe Zhang (ORCID: https://orcid.org/0009-0004-9608-6626)
Institutions
- Hebei Medical University (CN)
- Gomal University (PK)
- Gene Therapy Laboratory (FR)
- Hospital of Hebei Province (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Current Molecular Pharmacology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.2174/0118761429322420241112051105
- Citations
- 23
- Primary Topic
- Transgenic Plants and Applications
- Type
- article
- Field-Weighted Citation Impact
- 8.88
Funders
- National Natural Science Foundation of China